Back
Neuphoria Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
NEUP
Neuphoria Therapeutics, Inc.
Last Price:
$3.87
Seasonality Move:
517.18%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NEUP is experiencing slight selling pressure.
Neuphoria Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.95 | Sell |
| 20-day SMA: | 4.23 | Sell |
| 50-day SMA: | 6.08 | Sell |
| 200-day SMA: | 7.36 | Sell |
| 8-day EMA: | 3.98 | Sell |
| 20-day EMA: | 4.32 | Sell |
| 50-day EMA: | 5.88 | Sell |
| 200-day EMA: | 6.79 | Sell |
Neuphoria Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.54 | Sell |
| Relative Strength Index (14 RSI): | 36.63 | Sell |
| Chaikin Money Flow: | -17251 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.01 - 4.59) | Sell |
| Bollinger Bands (100): | (4 - 13.2) | Sell |
Neuphoria Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neuphoria Therapeutics, Inc. Stock
Is Neuphoria Therapeutics, Inc. Stock a Buy?
-
Neuphoria Therapeutics, Inc. share price is 3.89 while NEUP 8-day simple moving average is 3.95, which is a Sell signal.
-
The stock price of NEUP is 3.89 while Neuphoria Therapeutics, Inc. 20-day SMA is 4.23, which makes it a Sell.
-
Neuphoria Therapeutics, Inc. 50-day simple moving average is 6.08 while NEUP share price is 3.89, making it a Sell technically.
-
NEUP stock price is 3.89 and Neuphoria Therapeutics, Inc. 200-day simple moving average is 7.36, creating a Sell signal.
NEUP Technical Analysis vs Fundamental Analysis
Sell
44
Neuphoria Therapeutics, Inc. (NEUP)
is a Sell
Is Neuphoria Therapeutics, Inc. a Buy or a Sell?
-
Neuphoria Therapeutics, Inc. stock is rated a SellThe current Neuphoria Therapeutics, Inc. [NEUP] share price is $3.89. The Score for NEUP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Neuphoria Therapeutics, Inc. Stock Info
Market Cap:
7.3M
Price in USD:
3.89
Share Volume:
46.1K
Neuphoria Therapeutics, Inc. 52-Week Range
52-Week High:
21.40
52-Week Low:
0.23
Sell
44
Neuphoria Therapeutics, Inc. (NEUP)
is a Sell
Neuphoria Therapeutics, Inc. Share Price Forecast
-
What is the Neuphoria Therapeutics, Inc. stock price today?The Neuphoria Therapeutics, Inc. stock price is 3.89 USD today.
-
Will NEUP stock go up or go down?Neuphoria Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Neuphoria Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neuphoria Therapeutics, Inc. is overvalued.
Is Neuphoria Therapeutics, Inc. Stock a Buy?
-
Neuphoria Therapeutics, Inc. share price is 3.89 while NEUP 8-day exponential moving average is 3.98, which is a Sell signal.
-
The stock price of NEUP is 3.89 while Neuphoria Therapeutics, Inc. 20-day EMA is 4.32, which makes it a Sell.
-
Neuphoria Therapeutics, Inc. 50-day exponential moving average is 5.88 while NEUP share price is 3.89, making it a Sell technically.
-
NEUP stock price is 3.89 and Neuphoria Therapeutics, Inc. 200-day simple moving average is 6.79, creating a Sell signal.
Fundamental Analysis of Neuphoria Therapeutics, Inc.
Is Neuphoria Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.75 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $3.15 per share.
Technical Analysis of Neuphoria Therapeutics, Inc.
Should I short Neuphoria Therapeutics, Inc. stock?
-
NEUP Moving Average Covergence Divergence (MACD) indicator is -0.54, suggesting Neuphoria Therapeutics, Inc. is a Sell
-
Neuphoria Therapeutics, Inc. Relative Strength Index (RSI) is 36.63, which suggest Neuphoria Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Neuphoria Therapeutics, Inc. is (4.01 - 4.59), which suggest Neuphoria Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Neuphoria Therapeutics, Inc. is (4 - 13.2), which suggest Neuphoria Therapeutics, Inc. is a Sell
* Neuphoria Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.